David Kahn

David Kahn has extensive experience in the biopharmaceutical industry, having worked in various senior roles for multiple companies. David started their career at Genentech in 1993 as a Scientist and remained with the company for ten years. In 2003, they joined Human Genome Sciences as a Senior Director in Purification Sciences and held this position until 2013. Following this, they moved to MedImmune in 2014, where they served as a Senior Director in CMC Team Management until 2018. Currently, David is the Vice President of Biopharmaceutical Development at MacroGenics, Inc., a position they have held since September 2018.

David Kahn obtained a Bachelor of Science in Biology/Biological Sciences, General from Michigan State University between 1977 and 1980. Following this, they pursued a Ph.D. in Biochemistry at Virginia Tech from 1980 to 1985.